PaccMann^RL: Designing Anticancer Drugs with ...

In this episode, Diogo Almeida, co-founder and CEO of TypeSafe, joins us to discuss Jev, TypeSafe’s recently released model for bringing fast, reliable intelligence directly into software. We explore the idea of “machine-native intelligence” and why Diogo believes models optimize ...  Show more

AI systems have gone from struggling with grade-school math to helping solve research problems that have resisted mathematicians for decades, including Navier-Stokes. In this episode, Greg Burnham, who leads AI capabilities research at Epoch AI, joins us to examine what that prog ...  Show more

On today's show, we are joined by Michael Timothy Bennett, a Ph.D. student at the Australian National University. Michael's research is centered around Artificial General Intelligence (AGI), specifically the mathematical formalism of AGIs. He joins us to discuss findings from ...

In episode nine we talk with George Dahl, of  the University of Toronto, about his work on the Merck molecular activity challenge on kaggle and speech recognition. George recently successfully defended his thesis at the end of March 2015. (Congrats George!) We learn about how net ...  Show more

<span data-preserver-spaces="true">Today's guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is ...

In this episode, Ph.D. candidate in Neuroscience, Manesh Girn joins new podcast voice, Julian Bost, to explain recent research we found confusing, and to discuss schizophrenia, inflammation and depression, and the ways we learn. www.psychedelicstoday.com